Amedisys Stock In The News
| AMED Stock | USD 91.41 0.18 0.20% |
Our overall analysis of Amedisys' news coverage and content from conventional and social sources shows investors' bearish mood towards Amedisys. The specific impact of Amedisys news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Amedisys' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amedisys headlines in addition to utilizing other, more conventional financial analysis modules. Check out Amedisys Backtesting and Amedisys Hype Analysis. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Amedisys |
Amedisys Today Top News and Investor Outlook
Amedisys Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Amedisys and other traded companies coverage with news coverage. We help investors stay connected with Amedisys headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on Amedisys Stock performance. Please note that trading solely based on the Amedisys hype is not for everyone as timely availability and quick action are needed to avoid losses.
Amedisys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Amedisys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.
Amedisys Largest EPS Surprises
Earnings surprises can significantly impact Amedisys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2003-05-13 | 2003-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2002-11-11 | 2002-09-30 | 0.08 | 0.1 | 0.02 | 25 | ||
2014-05-08 | 2014-03-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2012-08-07 | 2012-06-30 | 0.24 | 0.27 | 0.03 | 12 | ||
2003-08-12 | 2003-06-30 | 0.09 | 0.12 | 0.03 | 33 | ||
2002-08-07 | 2002-06-30 | 0.16 | 0.13 | -0.03 | 18 |
Amedisys Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Amedisys Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
20th of November 2024
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. - MarketBeat at news.google.com
13th of November 2024
UnitedHealths 33B Deal With Hospice Provider Blocked By DOJ at ibtimes.com
11th of November 2024
Market Today DOJ Challenges UnitedHealths Amedisys Deal, AbbVies Setback at gurufocus.com
7th of November 2024
The Pennant Group, Inc. Q3 Earnings and Revenues Beat Estimates at finance.yahoo.com
5th of November 2024
Acquisition by Nick Muscato of 10421 shares of Amedisys subject to Rule 16b-3 at MacroaxisInsider
31st of October 2024
Short Interest in Amedisys, Inc. Drops By 8.4 at thelincolnianonline.com
25th of October 2024
UnitedHealth to Make Last Push for DOJ Blessing on Amedisys Deal at bnnbloomberg.ca
16th of October 2024
Will Amedisys Beat Estimates Again in Its Next Earnings Report at zacks.com
6th of September 2024
3 Reasons UnitedHealth Group Is One of the Best Dividend Stocks You Can Own at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.
Check out Amedisys Backtesting and Amedisys Hype Analysis. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.35) | Earnings Share 2.52 | Revenue Per Share 71.004 | Quarterly Revenue Growth 0.057 | Return On Assets 0.0627 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.